The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(5-(4-chlorophenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-2-(5-p-tolyl-1,3,4-oxadiazol-2-ylthio)ethanone ID: ALA4526118
PubChem CID: 155543337
Max Phase: Preclinical
Molecular Formula: C24H19ClN4O2S2
Molecular Weight: 495.03
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2nnc(SCC(=O)N3N=C(c4cccs4)CC3c3ccc(Cl)cc3)o2)cc1
Standard InChI: InChI=1S/C24H19ClN4O2S2/c1-15-4-6-17(7-5-15)23-26-27-24(31-23)33-14-22(30)29-20(16-8-10-18(25)11-9-16)13-19(28-29)21-3-2-12-32-21/h2-12,20H,13-14H2,1H3
Standard InChI Key: IMAMIWADQYFCJX-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
13.3543 -12.8439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3531 -13.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0612 -14.0724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7709 -13.6630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7680 -12.8403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0594 -12.4350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6451 -14.0715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4738 -12.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2216 -12.7561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7661 -12.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3548 -11.4405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5562 -11.6136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5791 -12.2291 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.0570 -11.5662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8700 -11.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3478 -10.9856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2052 -12.3938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1611 -10.9792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4107 -10.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7477 -9.7232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0885 -10.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3135 -9.9601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1403 -9.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3625 -8.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7573 -9.4623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9350 -10.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7126 -10.5089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1872 -9.9416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8501 -10.4194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5095 -9.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2540 -9.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4368 -9.1635 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.9784 -9.2151 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 2 0
5 8 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 16 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
21 22 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 28 1 0
19 28 1 0
25 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 495.03Molecular Weight (Monoisotopic): 494.0638AlogP: 6.23#Rotatable Bonds: 6Polar Surface Area: 71.59Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.61CX LogD: 5.61Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.30Np Likeness Score: -2.31
References 1. Fernandes GFDS, Fernandes BC, Valente V, Dos Santos JL.. (2019) Recent advances in the discovery of small molecules targeting glioblastoma., 164 [PMID:30583248 ] [10.1016/j.ejmech.2018.12.033 ] 2. Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V.. (2020) Recent advancements in the development of bioactive pyrazoline derivatives., 205 [PMID:32795767 ] [10.1016/j.ejmech.2020.112666 ]